Varenicline helps young people quit nicotine vaping regardless of cannabis use
A clinical trial shows varenicline effectively helps young adults quit vaping nicotine, even with concurrent cannabis use.Summary
A recent clinical trial conducted by Mass General Brigham investigated the effectiveness of varenicline, a medication used for nicotine cessation, in helping young people quit vaping. The study, published in JAMA Network Open, involved 261 participants aged 16-25 and found that varenicline was effective for vaping cessation regardless of their cannabis use. Researchers divided participants based on cannabis usage – no use, 1-3 days/week, or 4-7 days/week – and discovered that cannabis use did not hinder the ability to quit vaping. Varenicline was associated with higher rates of nicotine vaping abstinence compared to behavioral support alone, and it did not impact cannabis use rates. The study suggests that cannabis use shouldn't be a barrier to offering varenicline treatment for vaping cessation and highlights the need for increased access to such treatments for young people.
(Source：Medical News)
